Technology | Stethoscopes | November 19, 2015

Smart ECG Stethoscope Attachment Improves the Cardio-Diagnostic Processes

FDA-cleared device combines ECG, digital auscultation and mobile app integration with any existing stethoscope

Rijuven, CardioSleeve for Pediatrics, FDA clearance, stethoscopes

Image courtesy of Rijuven

November 19, 2015 — Rijuven announced the launch of CardioSleeve for Pediatrics, the first U.S. Food and Drug Administration (FDA)-cleared device that adds electrocardiogram (ECG) capabilities to transform any existing stethoscope into a smart, mobile-connected device. The system is complete with three-lead ECG, digital auscultation and real-time digital analysis optimized for pediatric care. With CardioSleeve, pediatricians and clinicians can quickly and accurately visualize heart sound, analyze for arrhythmia or murmur, and identify heart failure.

Through the synchronization of digital heart sound with ECG, CardioSleeve for Pediatrics makes all-new functionality possible, such as advanced murmur detection analysis at times when restless patients, noisy environments and rapid heart rate can make examinations challenging. CardioSleeve murmur detection analysis aids in the diagnosis of pathological and physiological heart sounds in patients as young as infants, at heart rates up to 180 beats per minute.

Pediatricians and clinicians simply attach the CardioSleeve to an existing stethoscope. The device quickly and accurately acquires the digital acoustic and electric footprints of the heart and transmits them to a mobile device for real-time analysis. This allows for the creation of the Systolic Performance Index, a measure of ejection fraction, critical to identifying heart failure.

CardioSleeve for Pediatrics and its companion mobile app features:

  • Digital auscultation with ECG;
  • Murmur detection and analysis at beats up to 180 BPM;
  • High fidelity three-lead ECG;
  • Systolic Performance Index;
  • Digital caliper;
  • FDA clearance for both device and analysis;
  • HIPAA-secure data transfer and cloud-based electronic medical record (EMR);
  • Wireless Bluetooth connectivity;
  • IOS, Android and PC compatibility;
  • Easy attachment to any traditional stethoscope; and
  • Dry-contact and biocompatible surfaces.

CardioSleeve for Pediatrics is part of the Rijuven i2Dtx platform. i2Dtx is a comprehensive, portable, cloud-based medical device platform for heart, lung, vital signs, imaging and lab clinical assessments for any physical examination.

The i2DTX platform includes a CardioSleeve and connected devices including an otoscope, pulse ox, IR thermometer and blood pressure cuff. Optional additions include a weight scale, spirometer, ultrasound, and blood glucose monitor. All devices can be wirelessly deployed to assess patients at any point of care. i2Dtx connects vitals, diagnostic, and lab devices with live notes, real-time consults, high definition (HD) photos for visual exams and a complete EMR report both in the facility and remotely.

For more information: www.rijuven.com

Related Content

With the advent and optimization of nuclear scintigraphy protocols using bone-avid radiotracers, cardiac amyloidosis caused by transthyretin protein (ATTR) can now be diagnosed noninvasively without a costly tissue biopsy. The radiotracer 99mTc-pyrophosphate (99mTc-PYP) binds to deposited ATTR amyloid fibrils in the myocardium and can be visualized using planar and SPECT imaging. Amyloidosis Patient Registry  #Amyloidosis

With the advent and optimization of nuclear scintigraphy protocols using bone-avid radiotracers, cardiac amyloidosis caused by transthyretin protein (ATTR) can now be diagnosed noninvasively without a tissue biopsy. The radiotracer 99mTc-pyrophosphate (99mTc-PYP) binds to deposited ATTR amyloid fibrils in the myocardium and can be visualized using planar and SPECT imaging. This is Figure 2, showing how SPECT imaging allows the reader to distinguish between blood pool activity (ventricular cavity, etc) and myocardial activity and identify regional myocardial differences in radiotracer uptake.

News | Cardiac Diagnostics | March 05, 2020
March 5, 2020 — More than 300 patients have joined the Amyloidosis Patient Registry and it is now available to the en
heart disease image
News | Cardiac Diagnostics | December 18, 2019
December 18, 2019 — In their latest report, “...
FDA Warns Troponin Tests Impacted by Biotin Dietary Supplement
Feature | Cardiac Diagnostics | November 05, 2019 | Dave Fornell, Editor
November 5, 2019 — The U.S.
Videos | Cardiac Diagnostics | October 29, 2019
Doctor Clyde Yancy was a keynote speaker and said doctors need to check their assumptions about patients at the door...
79-year-old Tony Marovic had a right carotid endarterectomy shortly after discovering a 95 percent blockage of his carotid artery at a health and wellness screening event

79-year-old Tony Marovic had a right carotid endarterectomy shortly after discovering a 95 percent blockage of his carotid artery at a health and wellness screening event. Image courtesy of University Hospitals.

News | Cardiac Diagnostics | October 16, 2019
Health and wellness screenings are more than just nice events for the community – they can save lives. A Mentor, Ohio,...
Pesticide Exposure May Increase Heart Disease and Stroke Risk

Image courtesy of zefe wu from Pixabay

News | Cardiac Diagnostics | October 15, 2019
On-the-job exposure to high levels of pesticides raised the risk of heart disease and stroke in a generally healthy...
World Heart Federation Launches Global Roadmap on Cardiovascular Disease Prevention Among Diabetics
News | Cardiac Diagnostics | September 04, 2019
At the European Society of Cardiology (ESC) Congress 2019 together with the World Congress of Cardiology, the World...
Insomnia Tied to Higher Risk of Heart Disease and Stroke

Image courtesy of the American Heart Association

News | Cardiac Diagnostics | August 19, 2019
People suffering from insomnia may have an increased risk of coronary artery disease, heart failure and stroke,...